首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Anaplastic lymphoma kinase-positive large B-cell lymphoma with a diagnostic pitfall of carcinoma: a case report
【2h】

Anaplastic lymphoma kinase-positive large B-cell lymphoma with a diagnostic pitfall of carcinoma: a case report

机译:间变性淋巴瘤激酶阳性大B细胞淋巴瘤与诊断性癌症陷阱:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+LBCL) is a rare non-Hodgkin lymphoma that exhibits a characteristic immunoblastic/plasmablastic morphology and is frequently expressing Clathrin-anaplastic lymphoma kinase fusion protein. Since being negative for T- and B- linage markers, this tumor is easy to be misdiagnosed, especially when it has unusual morphology and immunophenotype. Here, we report an ALK+LBCL with a diagnostic pitfall of carcinoma. The patient was a 28-year-old man with enlargement of a right submandibular lymph node. Morphologically, the lymph node had an unusual nodular growth pattern, with nodules surrounded by collagen bands. The neoplastic cells expressed epithelial membrane antigen, CD138, CD38, Mum-1, but negative for T- and B- linage markers, and showed a strong granular cytoplasmic Anaplastic Lymphoma Kinase staining pattern. Some tumor cells had the expressing of Cytokeratin.
机译:间变性淋巴瘤激酶阳性的大B细胞淋巴瘤(ALK + LBCL)是一种罕见的非霍奇金淋巴瘤,表现出特征性的免疫母细胞/浆母细胞形态,并经常表达网格蛋白-间变性淋巴瘤激酶融合蛋白。由于该肿瘤对T-和B-线性标记阴性,因此容易被误诊,尤其是当它具有异常的形态和免疫表型时。在这里,我们报告了ALK + LBCL与癌症的诊断陷阱。该患者是一名28岁的男子,右下颌下淋巴结肿大。从形态学上讲,淋巴结有异常的结节状生长,结节周围有胶原蛋白带。赘生性细胞表达上皮膜抗原CD138,CD38,Mum-1,但对T-和B-线性标记呈阴性,并显示强颗粒状的细胞质间变性淋巴瘤激酶染色模式。一些肿瘤细胞具有细胞角蛋白的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号